[1]甘 瀛.孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效[J].医学信息,2019,32(12):150-151.[doi:10.3969/j.issn.1006-1959.2019.12.049]
　GAN Ying.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children[J].Journal of Medical Information,2019,32(12):150-151.[doi:10.3969/j.issn.1006-1959.2019.12.049]
点击复制

孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的疗效()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年12期
页码:
150-151
栏目:
药物与临床
出版日期:
2019-06-15

文章信息/Info

Title:
Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Cough Variant Asthma in Children
文章编号:
1006-1959（2019）12-0150-02
作者:
甘 瀛
黑龙江省佳木斯市妇幼保健院儿科，黑龙江 佳木斯 154002
Author(s):
GAN Ying
Department of Pediatrics,Jiamusi Maternal and Child Health Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
肺功能; 布地奈德; 孟鲁司特钠; 咳嗽变异性哮喘
Keywords:
Key words：Pulmonary function; Budesonide; Montelukast sodium; Cough variant asthma
分类号:
R725.6
DOI:
10.3969/j.issn.1006-1959.2019.12.049
文献标志码:
A
摘要:
目的 探讨孟鲁司特钠联合布地奈德治疗小儿咳嗽变异性哮喘的临床疗效。方法 选择2017年2月~2018年5月我院收治的咳嗽变异性哮喘患儿90例，按照随机数字表法分为研究组和对照组，各45例。对照组给予布地奈德治疗，研究组在对照组基础上加用孟鲁司特钠治疗，比较两组第1秒用力呼气量（FEV1）、用力肺活量（FVC）、FEV1/FVC水平和临床疗效。结果 治疗后，研究组FEV1、FVC及FEV1/FVC水平高于对照组[（3.34±1.01）L vs（2.17±0.62）L、（4.23±1.31）L vs（3.19±1.05）L、（78.96±3.25）% vs（66.35±4.79）%]，差异有统计学意义（P＜0.05）。研究组总有效率为91.11%，高于对照组的80.00%，差异有统计学意义（P＜0.05）。结论 孟鲁司特钠联合布地奈德治疗咳嗽变异性哮喘效果明显，促进相关症状消退，改善肺功能，快速稳定病情，为预后提供保障。
Abstract:
Abstract：Objective To investigate the clinical efficacy of montelukast sodium combined with budesonide in the treatment of cough variant asthma in children. Methods 90 children with cough variant asthma admitted to our hospital from February 2017 to May 2018 were enrolled in the study group and the control group, 45 cases each according to the random number table method. The control group was treated with budesonide. The study group was treated with montelukast sodium on the basis of the control group. The forced expiratory volume (FEV1), forced vital capacity (FVC), FEV1/FVC levels, and clinical efficacy were compared between the two groups. Results After treatment, the levels of FEV1, FVC and FEV1/FVC in the study group were higher than those in the control group [(3.34±1.01)L vs(2.17±0.62)L, (4.23±1.31)L vs(3.19±1.05)L, (78.96± 3.25)% vs (66.35±4.79)%], the difference was statistically significant (P<0.05). The total effective rate of the study group was 91.11%, which was higher than that of the control group 80.00%,the difference was statistically significant (P<0.05). Conclusion Montelukast sodium combined with budesonide is effective in the treatment of cough variant asthma, promotes the related symptoms, improves lung function, and quickly stabilizes the disease, providing a guarantee for prognosis.

参考文献/References:

[1]吴海丽,李贤斌.气雾型布地奈德联合孟鲁司特钠治疗小儿咳嗽变异性哮喘疗效及对肺功能和血清炎症因子的影响[J].海南医学院学报,2016,22(5):467-469,473. [2]王军,丁娟娟.孟鲁司特钠联合布地奈德混悬液对哮喘急性发作患儿C-反应蛋白,肺功能及临床疗效的影响[J].中国生化药物杂志,2016,36(2):108-110. [3]魏延,李东升,刘建军,等.孟鲁司特钠联合布地奈德治疗儿童咳嗽变异性哮喘疗效和安全性的Meta分析[J].中国当代儿科杂志,2016,18(11):1100-1105. [4]Kim YH,Kim DW,Kwon MS,et al.Novel montelukast sodium-loaded clear oral solution prepared with hydroxypropyl-beta-cyclodextrin as a solubilizer and stabilizer:enhanced stability and bioequivalence to commercial granules in rats[J].Journal of Inclusion Phenomena and Macrocyclic Chemistry,2015,82(3-4):479-487. [5]吴莉菁,肖国军.孟鲁司特钠片联合布地奈德混悬液治疗咳嗽变异性哮喘患儿的临床研究[J].中国临床药理学杂志,2016,32(22):2032-2034,2038. [6]Kamna S,Rohit B,Durgadas A,et al.Development and Validation of UV-Spectrophotometric and RP-HPLC Methods for Simultaneous Estimation of Fexofenadine Hydrochloride,Montelukast Sodium and Ambroxol Hydrochloride in Tablet Dosage Form[J].Analytical Chemistry Letters,2018,8(6):829-843. [7]张娴,赵雪琴.孟鲁司特钠联合布地奈德治疗儿童哮喘的临床研究[J].中国临床药理学杂志,2016,32(13):1169-1171.

相似文献/References:

[1]李暾,徐伟,李强.ICU 病房应用无创呼吸机治疗老年COPD 并域型呼吸衰竭的临床疗效研究[J].医学信息,2018,31(01):106.[doi:10.3969/j.issn.1006-1959.2018.01.039]
　LI Tun,XU Wei,LI Qiang.Clinical Study of Noninvasive Ventilator in Elderly Patients with COPD and Type 域 Respiratory Failure in ICU Ward[J].Journal of Medical Information,2018,31(12):106.[doi:10.3969/j.issn.1006-1959.2018.01.039]
[2]刘成丽.氨溴索在哮喘性支气管炎治疗中的应用效果及安全性评价[J].医学信息,2018,31(05):138.[doi:10.3969/j.issn.1006-1959.2018.05.049]
　LIU Cheng-li.Efficacy and Safety Evaluation of Ambroxol in the Treatment of Asthmatic Bronchitis[J].Journal of Medical Information,2018,31(12):138.[doi:10.3969/j.issn.1006-1959.2018.05.049]
[3]马建娟.布地奈德联合异丙托溴铵雾化治疗COPD 急性加重期的效果评价[J].医学信息,2018,31(07):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
　MA Jian-juan.Efficacy Evaluation of Budesonide Combined with Ipratropium Bromide in Treatment of Acute Exacerbation of COPD[J].Journal of Medical Information,2018,31(12):141.[doi:10.3969/j.issn.1006-1959.2018.07.048]
[4]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(12):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[5]罗玉霞.舒适护理在布地奈德联合氨溴索雾化吸入治疗 慢阻肺急性发作患者的效果分析[J].医学信息,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
　LUO Yu-xia.Analysis of the Effect of Comfortable Nursing in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients with Aerosolized Inhalation of Budesonide and Ambroxol[J].Journal of Medical Information,2018,31(12):179.[doi:10.3969/j.issn.1006-1959.2018.12.058]
[6]张明荣.孟鲁司特钠联合布地奈德治疗小儿哮喘的临床疗效分析[J].医学信息,2018,31(13):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
　ZHANG Ming-rong.Clinical Analysis of Montelukast Sodium Combined with Budesonide in the Treatment of Childhood Asthma[J].Journal of Medical Information,2018,31(12):131.[doi:10.3969/j.issn.1006-1959.2018.13.038]
[7]李庆华.复可托治疗小儿反复肺炎支原体感染的疗效及对 免疫功能和肺功能的影响[J].医学信息,2018,31(16):128.[doi:10.3969/j.issn.1006-1959.2018.16.040]
　LI Qing-hua.Therapeutic Effect of Fuketuo on Recurrent Mycoplasma Pneumoniae Infection in Children and its Influence on Immune and Pulmonary Function[J].Journal of Medical Information,2018,31(12):128.[doi:10.3969/j.issn.1006-1959.2018.16.040]
[8]邱亚双.辛夷鼻炎丸联合布地奈德治疗变应性鼻炎的临床观察[J].医学信息,2019,32(03):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
　QIU Ya-shuang.Clinical Observation of Xinyi Biyan Wan Combined with Budesonide in Treating Allergic Rhinitis[J].Journal of Medical Information,2019,32(12):158.[doi:10.3969/j.issn.1006-1959.2019.03.052]
[9]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
　XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Journal of Medical Information,2018,31(12):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
[10]王 雪,章 晔,李宝华.孟鲁斯特钠片与异丙托溴铵和布地奈德混悬液雾化吸入对小儿呼吸道感染性咳嗽的临床疗效[J].医学信息,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
　WANG Xue,ZHANG Ye,LI Bao-hua.Clinical Effect of Montelukast Sodium Tablets Combined with Ipratropine Bromide and Budesonide Mixed Suspension Atomization Inhalation on Children with Respiratory Tract Infection Cough[J].Journal of Medical Information,2022,35(12):190.[doi:10.3969/j.issn.1006-1959.2022.12.049]
[11]凌春艳.布地奈德气雾剂联合孟鲁司特钠治疗老年咳嗽变异性哮喘的疗效[J].医学信息,2020,33(07):144.[doi:10.3969/j.issn.1006-1959.2020.07.046]
　LING Chun-yan.Efficacy of Budesonide Aerosol Combined with Montelukast Sodium in the Treatment of Elderly Cough Variant Asthma[J].Journal of Medical Information,2020,33(12):144.[doi:10.3969/j.issn.1006-1959.2020.07.046]
[12]王 瑜.布地奈德混悬液联合特布他林治疗小儿哮喘的效果[J].医学信息,2022,35(12):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
　WANG Yu.Effect of Budesonide Suspension Combined with Terbutaline in the Treatment of Pediatric Asthma[J].Journal of Medical Information,2022,35(12):184.[doi:10.3969/j.issn.1006-1959.2022.12.047]
[13]陈平兰.布地奈德混悬液联合异丙托溴铵雾化吸入治疗小儿支气管炎临床疗效与安全性研究[J].医学信息,2023,36(08):147.[doi:10.3969/j.issn.1006-1959.2023.08.032]
　CHEN Ping-lan.Study on Clinical Efficacy and Safety of Budesonide Suspension Combined with Ipratropium Bromide Aerosol Inhalation in the Treatment of Bronchitis in Children[J].Journal of Medical Information,2023,36(12):147.[doi:10.3969/j.issn.1006-1959.2023.08.032]
[14]穆妮热·麦麦提吐孙,阿卜杜凯尤木·库尔班.孟鲁司特钠联合布地奈德治疗小儿支气管哮喘的疗效及对患儿肺功能、外周血嗜酸性粒细胞的影响[J].医学信息,2023,36(21):138.[doi:10.3969/j.issn.1006-1959.2023.21.032]
　EosinophilsMunige·McMetitosun,Abdolkayum·Kurbane.Efficacy of Montelukast Sodium Combined with Budesonide in the Treatment of Bronchial Asthma in Children and its Effect on Lung Function and Peripheral Blood[J].Journal of Medical Information,2023,36(12):138.[doi:10.3969/j.issn.1006-1959.2023.21.032]

更新日期/Last Update: 2019-06-15